Invest in transforming microscopy to understand disease through 3D models
Get the latest on our breakthroughs, progress, and funding milestones.
For the first time, researchers can quantify biology inside 3D models with our software, Jellyfish.
At Ciprocity, we are enabling what was not possible before in confocal microscopy by correcting light attenuation in thick 3D samples.
“Ciprocity provides an alternative to accurately determine the amount of positive cells in our 3D models without loosing information due to light loss, avoiding time-loss and damaging the samples”
Patent-Pending Innovation for Better 3D Imaging
A first patent application has been filed and is now in the national phase, forming the foundation of our IP strategy.
Market Opportunity
3D cultures are transforming how we understand and treat disease, representing a high-impact market for Ciprocity.
Our solution sits at the intersection of the 3D cell culture market and the confocal microscopy market, offering new value from existing lab equipment while meeting the rising demand for more accurate research models.
3D Cell Culture MarketUSD 2.83 B
2025 Market Size
12.1%
CAGR (2025-2032)
USD 1.15 B
2025 Market Size
3.19%
CAGR (2025-2030)
Confocal Microscopy Market
Our Vision
Transforming confocal microscopy from imaging to quantitative measurements
Contact Us
We’re opening our first investment opportunities, contact us to join in enabling better science.